|
COX7A2L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02340000310386E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.71090002960051E-09 |
| Normal-vs-Stage2 |
1.821940E-04 |
| Normal-vs-Stage3 |
2.681600E-02 |
| Normal-vs-Stage4 |
1.327190E-01 |
| Stage1-vs-Stage2 |
5.606600E-01 |
| Stage1-vs-Stage3 |
5.046400E-02 |
| Stage1-vs-Stage4 |
2.256400E-01 |
| Stage2-vs-Stage3 |
2.894800E-01 |
| Stage2-vs-Stage4 |
4.168600E-01 |
| Stage3-vs-Stage4 |
9.544800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.65149999628878E-08 |
| Normal-vs-AfricanAmerican |
2.99390000002564E-06 |
| Normal-vs-Asian |
5.073600E-01 |
| Caucasian-vs-AfricanAmerican |
9.628400E-01 |
| Caucasian-vs-Asian |
3.820600E-01 |
| AfricanAmerican-vs-Asian |
4.043000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.83680026322986E-10 |
| Normal-vs-Female |
2.883800E-03 |
| Male-vs-Female |
1.116970E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.78240000000241E-05 |
| Normal-vs-Extreme_Weight |
6.09630002035288E-09 |
| Normal-vs-Obese |
2.19189999999259E-05 |
| Normal-vs-Extreme_Obese |
3.368200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.529400E-01 |
| Normal_Weight-vs-Obese |
7.594800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.195200E-01 |
| Extreme_Weight-vs-Obese |
1.488420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.904200E-02 |
| Obese-vs-Extreme_Obese |
3.467400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.652600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.12989999473601E-08 |
| Normal-vs-Age(61-80Yrs) |
4.2093999952364E-08 |
| Normal-vs-Age(81-100Yrs) |
9.89930000000472E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.558100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.068010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.627700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.247400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.625800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.858800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.18360029847054E-10 |
| Normal-VS-Type2 PRCC |
1.181650E-03 |
| Normal-VS-KIRP CIMP |
9.381400E-01 |
| Normal-VS-Unclassified PRCC |
1.359860E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.521800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.435700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.958000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.024200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.277800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.591700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.025800E-04 |
| Normal-vs-N1 |
5.455600E-02 |
| Normal-vs-N2 |
3.743400E-01 |
| N0-vs-N1 |
3.474600E-01 |
| N0-vs-N2 |
1.104200E-01 |
| N1-vs-N2 |
1.595170E-01 |
|
|
